AXONYX INC
10QSB, EX-27.1, 2000-11-09
PHARMACEUTICAL PREPARATIONS
Previous: AXONYX INC, 10QSB, 2000-11-09
Next: NEW ENGLAND INVESTMENT MANAGEMENT INC, 13F-NT, 2000-11-09



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      10,182,000
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            10,223,000
<PP&E>                                          44,000
<DEPRECIATION>                                   8,000
<TOTAL-ASSETS>                              10,310,000
<CURRENT-LIABILITIES>                           68,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        15,000
<OTHER-SE>                                  10,227,000
<TOTAL-LIABILITY-AND-EQUITY>                10,310,000
<SALES>                                        104,000
<TOTAL-REVENUES>                               104,000
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (3,996,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,996,000)
<EPS-BASIC>                                      (.27)
<EPS-DILUTED>                                    (.27)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission